Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases.
Couderc
L J
LJ
Service de Pneumologie, Hôpital Foch, Suresnes, France.
Stelianides
S
S
Frachon
I
I
Stern
M
M
Epardeau
B
B
Baumelou
E
E
Caubarrere
I
I
Hermine
O
O
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects* / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000209:etiology*; D012189:Retrospective Studies; D014751:Vindesine / Q000008:administration & dosage
D001761:Bleomycin; D016179:Granulocyte Colony-Stimulating Factor; D004317:Doxorubicin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003520:Cyclophosphamide; D014751:Vindesine; D008775:Methylprednisolone; D008727:Methotrexate